A role for regulatory T cells in renal acute kidney injury

Transplant Immunology

Volumn 21, Issue 1, 2009, Pages 50-55

  Monteiro, Rebecca M M ^a,b   Camara, Niels O S ^a,b   Rodrigues, Mauricio M ^c   Tzelepis, Fanny ^c   Damião, Marcio J ^a   Cenedeze, Marcos A ^a   Teixeira, Vicente de Paula A ^d   dos Reis, Marlene A ^d   Pacheco Silva, Alvaro ^a,e  

^a Nephrology Division   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UFTM   (Brazil)

^e HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Acute renal failure; Anti CD25 (PC61); Anti GITR (DTA 1); HO 1; Ischemia and reperfusion injury; TCD4+ lymphocytes

Indexed keywords

BASILIXIMAB; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DTA 1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UREA BLOOD LEVEL;

ANIMALS; BLOOD UREA NITROGEN; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HEME OXYGENASE-1; KIDNEY; KIDNEY FAILURE, ACUTE; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED C57BL; PROLIFERATING CELL NUCLEAR ANTIGEN; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 64049097100     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.02.003     Document Type: Article

References (45)

1. Bonventre J.V. Mechanisms of ischemic acute renal failure. Kidney Int 43 5 (1993) 1160-1178
2. Bonventre J.V., and Weinberg J.M. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14 8 (2003) 2199-2210
3. Molitoris B.A. Acute renal failure. Drugs Today (Barc) 35 9 (1999) 659-666
4. Cecka M. Clinical outcome of renal transplantation. Factors influencing patient and graft survival. Surg Clin North Am 78 1 (1998) 133-148
5. Daemen M.A., De Vries B., and Burman W.A. Apoptosis and inflammation in renal reperfusion injury. Transplantation 73 11 (2002) 1693-1700
6. Haug C.E., Colvin R.B., Delmonico F.L., Auchincloss H., Tolkoff-Rubin N., Preffer F.I., et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55 4 (1993) 766-772
7. Kelly K.J., Williams W.W., Colvin R.B., and Bonventre J.V. Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A 91 2 (1994) 812-816
8. Goggins W.C., Pascual M.A., Powelson J.A., Magee C., Tolkoff-Rubin N., Farrel M.L., et al. A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 76 5 (2003) 798-802
9. Yokota N., Daniels F., Crosson J., and Rabb H. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 74 6 (2002) 759-763
10. Khandoga A., Hanschen M., Kessler J.S., and Krombach F. CD4 T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 43 2 (2006) 306-315
11. Yokota N., Burne-Taney M., Racusen L., and Rabb H. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 285 2 (2003) F319-F325
12. Rabb H., Daniels F., O'Donnel M., Hag M., Saba S.R., Keane W., et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol 279 3 (2000) 525-531
13. Burne M.J., Daniels F., El Ghandour A., Mauiyyedi S., Colvin R.B., O'Donnel M.P., et al. Identification of the CD4+ T cells as major pathogenic factor in ischemic acute renal failure. J Clin Invest 108 9 (2001) 1283-1290
14. Zwacka R.M., Zhang Y., Halldorson J., Schlossberg H., Dudus L., and Engelhardt J.F. CD4+ T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 100 2 (1997) 279-289
15. Van Putte B.P., Kesecioglu J., Hendriks J.M., Persy V.P., van Marck E., Van Schil P.E., et al. Cellular infiltrates and injury evaluation in a rat model of warm pulmonary ischemia-reperfusion. Crit Care 9 1 (2005) R1-R8
16. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 3 (1995) 1151-1164
17. Baecher-Alan C., and Anderson D.E. Regulatory cells and human cancer. Semin Cancer Biol 16 2 (2006) 98-105
18. Chatila T.A. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 116 5 (2005) 949-959
19. Mills K.H. Regulatory T cells: friend or foe in immunity to infection?. Nat Rev, Immunol 4 11 (2004) 841-855
20. Battaglia M., and Roncarolo M.G. Induction of transplantation tolerance via regulatory T cells. Inflamm Allergy Drug Targets 5 3 (2006) 157-165
21. Suffia I., Reckling S.K., Salay S., and Belkaid Y. A role for CD103 in the retention of CD4CD25 TReg and control of Leishmania major infection. J Immunol 174 9 (2005) 5444-5455
22. Powrie F., Leach M.W., Mauze S., Caddle L., and Coffman R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 SCID mice. Int Immunol 5 11 (1993) 1461-1471
23. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192 2 (2002) 303-310
24. Mc Hugh R.S., Whitters M.J., Piccirillo C.A., et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16 2 (2002) 311-323
25. Yamaguchi T., Hirota K., Nagahama K., Ohkawa K., Takahashi T., Nomura T., et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27 1 (2007) 145-159
26. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., and Levings M.K. Interleukin-10 secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212 (2006) 28-50
27. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 5609 (2003) 1057-1061
28. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 4 (2003) 330-336
29. Khattri R., Cox T., Yasako S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ regulatory T cells. Nat Immunol 4 4 (2003) 337-342
30. Wildin R.S.F., Ramsdell J., Peake F., Faravelli J.L., Buist E., Levy-Lahad M., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 1 (2001) 18-20
31. Busko T.M., Wasserfall C.H., Agarwal A., Kapturczak M.H., and Atkinson M.A. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J Immunol 174 9 (2005) 5181-5186
32. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446 7136 (2007) 685-689
33. Choileain N.N., MacConmara M., Zang Y., Murphy T.J., Mannick J.A., and Lederer J.A. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 176 1 (2006) 225-236
34. Lowenthal J.W., Corthésy P., Tougne C., Lees R., MacDonald H.R., and Nabholz M. High and low affinity IL-2 receptors: analysis by IL-2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J Immunol 135 6 (1985) 3988-3993
35. Shimizu J., Yamazaki S., and Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163 10 (1999) 5211-5218
36. Onizuka S., Tawara I., Shimizu J., Sakaguchi S., Fujita T., and Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59 13 (1999) 3128-3133
37. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., and Sakaguchi S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3 2 (2002) 135
38. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101 5 (2000) 455-458
39. Camara N.O., and Soares M.P. Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic Biol Med 38 4 (2005) 426-435
40. Fujita T., Toda K., Karimova A., Yan S.F., Naka Y., Yet S.F., et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by depression of fibrinolysis. Nat Med 7 5 (2001) 598
41. Yet S.F., Perrella M.A., Layne M.D., Hsieh C.M., Maemura K., Kobzik L., et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103 8 (1999) R23-R29
42. Yet S.F., Tian R., Layne M.D., Wang Z.Y., Maemura K., Solovyeva M., et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89 2 (2001) 168-173
43. S.G. Tullius, M. Nieminen-Kelha, R. Buelow, A. Reutzel-Selke, P.N. Martins, J. Pratschke et al., Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002; 74(5):591-8.
44. Shevach E.M., and Stephens G.L. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?. Nat Rev Immunol 6 8 (2006) 613-618
45. Kanamaru F., Youngnak P., Hashiguchi M., Nishioka T., Takahashi T., Sakaguchi S., et al. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J Immunol 172 12 (2004) 730